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Parkinson's diseaseOne of the hallmarks of sporadic Parkinson's disease is degeneration of dopaminergic neurons in the pars
compacta of the substantia nigra. The aetiopathogenesis of this degeneration is still not fully understood, with
dysfunction of many biochemical pathways in different subsystems suggested to be involved. Recent advances
in constraint-based modelling approaches hold great potential to systematically examine the relative contribu-
tion of dysfunction in disparate pathways to dopaminergic neuronal degeneration, but few studies have
employed these methods in Parkinson's disease research. Therefore, this review outlines a framework for future
constraint-based modelling of dopaminergic neuronal metabolism to decipher the multi-factorial mechanisms
underlying the neuronal pathology of Parkinson's disease.
© 2015 Mao et al. Published by Elsevier B.V. on behalf of the Research Network of Computational and Structural
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After Alzheimer's disease, sporadic Parkinson's disease (PD) is the
second most common neurodegenerative disorder, affecting about
0.3% of the entire population, 1% of people over 60 years of age and
up to 4% of those over 80 years of age [1]. In PD, neuronal populations
located within several anatomical locations appear to have different+352 466 644 5514.
Fleming).
n behalf of the Research Network of Csusceptibility to neurodegeneration [2,3], although the classical motor
symptoms of the disease result from degeneration of dopaminergic
neurons (DNs) in the substantia nigra pars compacta [1,3]. Despite in-
tensive research, the cause and biochemical mechanisms of dopaminer-
gic neuronal death in PD are incompletely understood. Proteostasis,
oxidative stress, mitochondrial dysfunction, excitotoxicity, neuro-
inﬂammation and more recently gut microbial dysbiosis have all been
associatedwith PD [4–8]. However, the relationship between these pro-
cesses is poorly understood, especially with regard to the causes, effects
and the relative importance of each dysregulated process in PD. Thisomputational and Structural Biotechnology. This is an open access article under the CC BY
485L. Mao et al. / Computational and Structural Biotechnology Journal 13 (2015) 484–491review summarises some molecular pathological features of selective
dopaminergic neuronal degeneration, discusses recent advances in
systems-level computational approaches, and presents a framework
based on several key methods of constraint-based modelling that we
envisage will help unravel aetiopathogenesis of PD.
2. Aspects of molecular pathogenesis in Parkinson's disease
Substantia nigra DNs consume a large amount of energy tomaintain a
tonic electrophysiological activity in their axonal terminals within the
striatum, making these cells especially vulnerable to any impairment of
energy metabolism [9]. In energy metabolism, oxidisation of nutrients
(e.g., glucose) is kinetically coupled to reduction of cofactors (e.g., NAD+
reduced to NADH, prosthetic group FAD reduced to FADH_2, NADP+ re-
duced to NADPH). In turn, oxidation of reduced cofactors is kinetically
coupled to generation of energy currency metabolites (e.g., ATP, GTP).
Energy currency metabolites are used to drive otherwise thermody-
namically unfavourable reactions that are required for maintenance
of normal cellular functions, such as scavenging of reactive oxidative
species (ROS), or in the case of DNs the synthesis, release and reuptake
of dopamine [10]. Oxidisation of reduced cofactors can also be used to
directly to drive certain biosynthesis reactions.
Modulation of NAD+-dependent enzymes is currently being
explored to treat neurological illnesses, e.g., the key NAD+-dependent
enzymes SIRT1 and SIRT2, which have been associated with the
α-synuclein aggregation process in PD [11]. Furthermore, in a previous
study, a parenteral application of NADH in PD patients resulted in in-
creased endogenous L-DOPA (L-3,4-dihydroxyphenylalanine) biosyn-
thesis and alleviation of the disease motor symptoms [12].
Moreover, degenerating DNs are accompanied by an increased
iron accumulation [13] and also excrete neuromelanin (NM) [14] and
ROS, which are responsible for microglia activation. These factors con-
tribute to excessive neuroinﬂammation, which may exacerbate neuro-
nal death [5,15]. Recent evidence has also shown the existence of
synergy between neuroinﬂammation in PD and gene products linked
to Parkinsonian phenotypes (such as α-synuclein, parkin, Nurr1, and
regulator of G-protein signalling-10) [16]. A previous study using a PD
mouse model found that the activation of glial cells can induce theFig. 1.The conceptual schemeof the constraint-basedmodelling approach to decipher Parkinson
ofmetabolites through reactions; exometabolomicsmeasures the abundance of primary and sec
ducted by the constraint-basedmodellingmethods are indicated by the light-yellow halo, wher
the light-green halo. RT-PCR, reverse transcription-polymerase chain reaction; DN, dopaminer
trometry; CE-TOFMS, capillary electrophoresis time-of-ﬂight mass spectrometry; 2DE, two-dimexpression of cyclooxygenase-2 (COX-2) in DNs, enhancing the suscep-
tibility of DNs to degeneration [17].
3. Computational systems approaches to dopaminergic
neuronal metabolism
Elucidation of the molecular aetiopathogenesis of PD requires an
interdisciplinary systems approach [18] to understand how dysfunc-
tions of disparate pathways interact to result in neurodegeneration
(Fig. 1). A systems approach consists of an iterative cycle of mathemat-
ical model formulation, computational modelling and quantitative ex-
perimental measurements. Mathematical and computational models
are formal representations of biochemical knowledge that are used
to propose hypotheses, design experiments and interpret experimental
results. Quantitative experimental measurements are used to test hy-
potheses generated by a model and also generate data used to reﬁne
the content of a model.
An ultimate aim of the application of a systems approach to PD
would be to be able to make non-trivial predictions of DN reactions,
where quantitative modulation would either signiﬁcantly imbalance
normal DN energy supply, or re-balance DN energy supply in DNs gen-
erated from induced pluripotent cells derived from PD patients. At the
core of this approach is an effort to reconstruct a state-of-the-art meta-
bolic network of substantia nigra DNs, and then to apply computational
modelling for generating experimentally testable hypotheses as to the
aetiopathogenic nature of PD.
Network reconstruction is a prerequisite for computational model-
ling. A high-quality reconstruction is built from a variety of biological
knowledge sources such as genome annotations, metabolic databases
(e.g., KEGG and BRENDA) and biochemical literature manually curated
in a quality-controlled manner [19]. These genome-scale network re-
constructions provide a detailed and self-consistent representation of
biochemical reaction networks and provide a basis for computation of
biochemically feasible functional states using computational modelling,
e.g., constraint-based modelling.
Constraint-based modelling is a scalable computational modelling
approachwidely used for prediction of physicochemically and biochem-
ically feasible steady-state metabolic ﬂuxes (reaction rates) in living' disease. Fluxomics quantiﬁes the reaction rates that describe the time-dependent passage
ondarymetabolites in the extracellular environment. Themodelling tasks that can be con-
eas quantitative analysis that needs to be validated by experimental tools are indicated by
gic neuron. NMR, nuclear magnetic resonance; GC–MS, gas chromatography–mass spec-
ensional gel electrophoresis; 13C-MFA, 13C metabolic ﬂux analysis.
1 http://humancyc.org.
486 L. Mao et al. / Computational and Structural Biotechnology Journal 13 (2015) 484–491cells [20]. Here, a steady state invokes the assumption that the concen-
trations of eachmetabolite are time invariant, while certainmetabolites
are consumed or produced by exchange reactions that translocate spe-
ciﬁc molecules across the boundary of the system being studied. This
approachwas successfully applied in various biomedical and biotechno-
logical contexts, including prediction of exchange ﬂuxes in human me-
tabolism, e.g., [21].
Software platforms have been developed to automate certain steps
of the reconstruction process [22]. However, these algorithms aremost-
ly suited to microbial metabolic network reconstruction and need to be
adapted for use when reconstructing metabolic networks in multi-
cellular organisms, where the metabolic function of each cell type has
evolved to be interdependent with the function of other cell types in
the body. For example, in constraint-based modelling of microbial me-
tabolism, one often optimises a biomass reaction that represents the
material and energy costs associated with cell replication. In contrast,
for a mature DN, which does not divide, perhaps the main metabolic
objective is to maximise the rate of energy generation to meet the de-
mand to tonically propagate action potentials over a large axonal arbor.
4. Constraint-based modelling of neuronal metabolism
Relatively small scale computational models were developed and
applied to investigate particular aspects of DNmetabolic reaction kinet-
ics, e.g., predicting dysregulation of dopamine homeostasis [23] and the
role of oxidative stress [24] in PD. Phenomenological kinetic modelling
is not suited to elucidate multi-factorial mechanisms underlying neuro-
degeneration at genome-scale due to (i) the paucity of data on enzyme
kinetic parameters, and (ii) the intractability of currently available ki-
netic modelling algorithms. Many of the kinetic parameters used in ki-
netic modelling studies are associated with large uncertainty because
they were acquired from in vitro rather than in vivo measurements.
Compared with kinetic modelling, constraint-based modelling ap-
proach requires fewer parameters and uses algorithms that are still trac-
table even when modelling large biochemical systems.
Research efforts have recently been devoted to reconstruct neuronal
cell metabolism [25,26]. The latter reconstruction comprises 524metab-
olites and 630 reactions, encoded by 570 genes. This network is centred
to integrate general knowledge of neuronal cells and further experimen-
tal validation with metabolomics or ﬂuxomics data. Another study
reconstructed an abstract model of DN metabolism [27] consisting
of only 111 metabolites and 139 reactions. However, excluding so
many metabolic reactions can reduce the predictive power of the corre-
sponding model. Furthermore, all of the aforementioned models do not
take into account the fact that midbrain DNs at different anatomical
locations do have distinct neurochemical phenotypes and exhibit differ-
ential vulnerability to degeneration in PD.
Comprehensive and anatomically resolved experimental gene ex-
pression datasets have recently become available, e.g., Allen brain atlas
[28]. Such datasets permit new computational approaches to investi-
gate the relationship between anatomy, cellular molecular phenotype
and selective neuronal vulnerability in PD. Reconstruction of the DN
metabolic network can be also greatly accelerated by the recent release
of the latest genome-scale humanmetabolic reconstruction, i.e., Recon 2
[21]. Recon 2 is a generic reconstruction in the sense that it contains
metabolic reactions from all cell types of the human body. A draft recon-
struction for a particular cell type can be generated fromRecon 2 byﬁrst
extracting a core set of reactions that are likely to be active in that cell
type, based on some set of omics data (e.g., transcriptomics, proteomics,
metabolomics).
A typical set of core reactions is usually not ﬂux consistent, i.e., not
every reaction has a non-zeroﬂux in at least one steady state ﬂux vector.
A number of methods have been developed to reconstruct context-
speciﬁc models from existing genome-scale models by integrating
various types of high-throughput data (as reviewed in [29]). The most
recently published algorithm is FASTCORE [30], which is devised toefﬁciently add additional reactions to ﬁll gaps in the cell-type-speciﬁc
network in order to yield aﬂux consistent network. FASTCORE can elim-
inate the inconsistency between ﬂuxes and gene expressions for the
network reconstruction by using linear optimisation to favour ﬂuxes
through reactions with gene expression above a certain threshold and
disfavour ﬂuxes through reactions with expression lower than the
threshold. The algorithm takes as input a global metabolic model and a
set of reactions that is already known to be active in a given context,
and it produces a context-speciﬁc model. The customised choice of ﬂux
threshold is critical as it discriminates expressed and non-expressed re-
actions, that is, any reactions that carry ﬂuxes higher than the chosen
threshold value are identiﬁed as expressed and must then be present
in the cell-type-speciﬁc network.
4.1. Reconstruction of cell-type speciﬁc DN metabolism
Network reconstruction is an iterative effort, and the procedure is
nowwell established for metabolic networks [19]. A previous study de-
veloped a workﬂow that integrates gene expression data, proteomics
data and literature-based manual curation to generate human gluta-
matergic, GABAergic and cholinergic mitochondrial metabolic recon-
structions based on a generic human metabolic reconstruction [31].
The overall workﬂow for the reconstruction of DN metabolism is the
same, comprising of two main stages (Fig. 2). In the stage of obtaining
a draft cell-speciﬁc neuronal network, the community generated con-
sensus reconstruction of human metabolism, i.e., Recon 2 [21], can be
used as a template, then specialised and extended to represent the
known metabolic functions of DNs in normal and disease states.
To accelerate the reconstruction process, the development of an
automated framework is required to support the manual effort associ-
ated with literature curation. Speciﬁcally, based on existing features of
established constraint-based modelling software, e.g., The COBRA tool-
box [32], it is necessary to add supplementary features speciﬁc to neuro-
nal network reconstruction. The stages of reconstruction guidelines are
listed in Table 1, as well as the processes and software involved. Some
steps in the reconstruction of DN metabolism can be performed by
existing COBRA functions, while others require the development of
new COBRA functions. The automated steps can be checked against ex-
perimental evidence, and software inputs and outputs can be manually
evaluated to detect potentialmisspeciﬁcation by automated reconstruc-
tion algorithms. Later, in the stage of validation, the reconstruction can
be compared with reaction stoichiometry from previous dynamic
models [24,23], non-speciﬁc neuron models [26] and an abstract DN
model [27]. Previously developed software tools can be used as exter-
nal simulation platforms to add notes, references and conﬁdence scores
supporting the inclusion of each reaction to the reconstruction and
convert the reconstruction into the standard model exchange format
(SBML Level 3).
A draft reconstruction is developed to include as large a part of
cell metabolism as possible and as much biological information as
possible. Several reconstruction steps, such as the genome annotation
and reconstruction of metabolic pathways, can be facilitated by auto-
mated computer-based tools, using biochemical information retrieved
from a number of freely or commercially available metabolic databases,
such as KEGG [34], BRENDA [35], UniProt [36], and HumanCyc [37]. The
determination of the gene–proteins–reaction associations (GPRs) asso-
ciatedwith eachmetabolic reaction is typically conducted by a laborious
and time-consuming literature search. It is thus worthwhile to develop
software tools to automate the process of adding GPR rules during the
reconstruction process with reference to four different ways of relating
genes, proteins and reactions (Fig. 3). For example, gene annotations
can be retrieved fromonline databases such asHumanCyc1. These anno-
tations establish relationships between genes and the production of
Fig. 2. Flowchart depicting the model development steps for cell-type speciﬁc reconstruction and constraint-based analyses.
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bases such as UniProt,2 the relationship between the genes and the pro-
teins can be determined. Then, the reactions associated to each protein
can be retrieved from databases such as KEGG3 and BRENDA,4 using en-
zyme identiﬁers such as EC numbers. Therefore, GPR associations can be
established by integrating inferred relationships between genes and
peptides, peptides and proteins, and proteins and reactions. Parts of
the integration process could be facilitated and automated by develop-
ing new software. It is also required to develop algorithms that correct
the discrepancies in biological identiﬁers that may exist in data repre-
sentations across different data sources [38]. Despite the advantages of
automation, the resultsmust be considered draft reconstruction compo-
nents, until manually checked for correctness.
During a reconstruction effort, particular care must be given to
the reconstruction of metabolic pathways unambiguously genetically
and experimentally associated with PD, e.g., glucocerebrosidase in
sphingolipid metabolism [39], and mitochondrial oxidative phosphory-
lation metabolism. Experimental studies of DNs in PD showed that
the dysfunction of oxidative phosphorylation is due to reduced activity
of NADH-ubiquinone reductase (Complex I) and NADH cytochrome C
reductase [40]. Oxidative phosphorylation consumes NADH, which is
supplied by three main pathways: glycolysis, TCA cycle and fatty acid
oxidation, to then produceATP,which is the fuel currency of various cel-
lular functions. Since NADH is commonly used in reactions related to2 http://www.uniprot.org.
3 http://www.genome.jp/kegg/.
4 http://www.brenda-enzymes.org.energy metabolism and was recently suggested as a reporter molecule
for PD by in silico modelling [27], it is necessary to prioritise balancing
these endogenous redox mediators in the context of oxidative phos-
phorylation, glycolysis, TCA cycle and fatty acid oxidation.
The metabolic pathways of oxidative phosphorylation can be
established by deﬁning the biochemical reactions with reference to a
list of mitochondrial databases (Table 2). A reconciliation of incomplete
and contradictory information fromdifferent databases is needed to ob-
tain details about the localisation of the enzymes, the speciﬁcity of intra-
cellular transporters and cofactor preferences. Based on data reliability,
the reactions included in the cell-speciﬁc network reconstruction can
be assigned different conﬁdence scores, for example, a high score can
be assigned to a reaction with strong evidence, whereas a lower score
for reactions with insufﬁcient evidence.
A table of the available ‘omics’ resources can be ranked and assem-
bled in order of suitability, which can help leverage existing investment
in the generation of data. As no published study has yet reconstructed
the cell-type speciﬁc DN metabolic network at genome-scale, there is
a need to establish some principles and a useful checklist to ensure
the integrity and quality of the reconstruction of DN metabolism.
4.2. Model reﬁnement by incorporation of experimental data
Relevant metabolomics and ﬂuxomics data, and manual curation
of biochemical literature are required to ensure the integrity and high-
quality of a metabolic reconstruction (Fig. 1). With the aid of pro-
gramming tools, these omics data can be translated into different
types of constraints, such as, lower and upper bounds of individual re-
action ﬂuxes, reaction directions and ratios of the reaction ﬂuxes. The
Table 1
The stages of the published reconstruction guidelines and implementation of the software platform.
Stages of the reconstruction
guideline
Required activities for constraint-based modelling of the DN metabolism Available software tools or actions
Draft reconstruction Assemble a draft reconstruction using Recon2 as template and include candidate metabolic
reactions and functions.
Context-speciﬁc metabolic network
reconstruction algorithms [29] e.g., FASTCORE
Reﬁnement/curation Determine metabolic functional requirements (e.g., dopamine production, maintaining tonic
ﬁring at different frequencies)
No suitable software
Add transport reactions/constraints to represent the transit between compartments
Reﬁnement and assignment of GPR rules COBRA functions
Reconstruction of metabolic pathways for neuronal mitochondrial phosphorylation.
Balancing different pairs of redox cofactors, including: NADH/NAD+, NADPH/NADP+ and
ATP/ADP balancing.
Require to develop new functions based on
available software
Database and information integration, for example, retrieval of metabolites and biochemical
reactions from a range of mitochondrial databases
Determine substrate usage and cofactors
Determine and add conﬁdence scores
Add references and notes
Flag cell-type-speciﬁc information on DN
Add ATP-maintenance reaction
Conversion to a
genome-scale model
COBRA functions
Network evaluation Test for stoichiometrically balanced cycles (no software can yet test for such cycles universally) Identiﬁable by ORCA [33] and resolved by
COBRA functions
Test the production of different precursors Reﬁnement of existing COBRA functions
Test different physiological properties Reﬁnement of existing COBRA functions
Relationships between competing functions ORCA functions
Model-driven discovery Multi-objective based sensitivity analysis to identify reactions supporting the
neurophysiological activities
ORCA functions
Test the robustness of the metabolic reconstruction COBRA functions
Identify the genes linked to PD aetiology COBRA functions
488 L. Mao et al. / Computational and Structural Biotechnology Journal 13 (2015) 484–491incorporation of experimentally obtained datasets can improve the pre-
dictive power and reliability of the DN model by shrinking the solution
space that contains all possible ﬂux solutions calculated in constraint-
based modelling.
4.2.1. Fluxome
Metabolic ﬂuxes can be estimated using 13C-based metabolic ﬂux
analysis (13C-MFA), in which intracellular ﬂuxes are quantitatively
determined by culturing cells in the presence of a 13C isotopically
labelled carbon source and tracing the transition path of the labelled
atoms between metabolites in the biochemical network using mathe-
matical modelling [41]. In addition, the kinetic parameters of reac-
tions can be estimated and converted into inequality bounds on
metabolite concentrations in FBA modelling [42,43]. Through integra-
tion of metabolite kinetics with FBA simulations, it is possible to im-
prove the predictive accuracy of the metabolic model by reducing
the solution space of the FBA model and unravel relationships be-
tween the abundance of substrate, products, cofactors, activators and
inhibitors.Fig. 3. Examples of detailed gene–protein–reaction (GPR) associations. (1) Simple association, i
codedistinct proteins carrying out the same function. (3)Multimeric protein complex, wherein
(4) Multifunctional protein, in which a single protein can carry out multiple reactions.4.2.2. Exometabolome
Extracellular metabolite abundances (the exometabolome) can be
quantiﬁed using in vitro cultures of DNs derived from human neural
stem cells. By analysing the exometabolomic data, the metabolomic
proﬁle of energy metabolism can be elucidated at different metabolic
states of the cell, using previously developed protocols [44]. Measured
metabolite uptake and secretion rates in dopaminergic neuronal cell
cultures can be used to curate a metabolic network reconstruction and
ﬁne-tune the parameters of the computational model. A recent study
has developed a workﬂow to predict the intracellular metabolic states
based on extracellular metabolomics data [45]. This is one way to im-
prove the predictive capability of a constraint-based model for com-
puting intracellular ﬂux distributions.
4.2.3. Manual curation of biochemical literature
Extensive manual curation of the experimental literature provides
valuable data for a cell-type speciﬁc dopaminergic neuron recon-
struction, especially central metabolic pathways, including glycolysis,
the TCA cycle and oxidative phosphorylation. Cell-type speciﬁc genenwhich a single gene encodes a single enzyme. (2) Isozymes, in which multiple genes en-
multiple genes encoding distinct protein subunits come together to form an active enzyme.
Table 2
List of useful databases for reconstruction of DN mitochondrial sub-network and data analysis.
Database Function Website
Genome annotation
Mitocarta An inventory of 1098 mouse genes encoding proteins with strong support of mitochondrial localisation. http://www.broadinstitute.org/pubs/mitocarta/
Proteins/nucleotides
Mitop2 Search for comprehensive information of mitochondrial proteins in human http://www.mitop2.de/
Mitominer An integrated web resource of mitochondrial proteomics http://mitominer.mrc-mbu.cam.ac.uk
Mitoproteome A collection of human mitochondrial protein sequences generated from information obtained from a
comprehensive curation of public databases as well as from direct experimental evidence.
http://www.mitoproteome.org/
Hmpdb Contains comprehensive data on mitochondrial and human nuclear-encoded proteins involved in
mitochondrial biogenesis and function.
http://bioinfo.nist.gov/
Functional/pathway
Mitophenome Search for genes and genetic variation and their effects on clinical disease phenotypes. http://www.mitoproteome.org/
489L. Mao et al. / Computational and Structural Biotechnology Journal 13 (2015) 484–491expression data can be manually retrieved from the Allen brain atlas,5
which is quite time-consuming, resulting in a need to develop software
and algorithms to automate certain processes, such as retrieval of neu-
roanatomical and neurobiochemical data for network reconstructions
for other cell types such as microglia and astrocytes. In addition, ex-
change reaction rates could be retrieved for dopaminergic neurons
from literature. These exchange reaction rates can serve as input/output
constraints to a constraint-basedmetabolic model. They can be used for
the dopaminergic neuronal metabolic reconstruction, and later for sim-
ulation of valid metabolic states for computational modelling of normal
and diseased states.
4.2.4. Image analysis
It is important to develop and apply software to quantify spatiotem-
porally resolved morphological features from ﬂuorescent images of do-
paminergic neurons in cell culture. By quantiﬁcation of the abundance
andmorphology of dopaminergic neurons in vitro, it is possible to com-
pare metabolomic and mass isotopomer abundance data from different
cultures, by normalising to the dopaminergic neuronal cell volume in
each culture. Automated incorporation of the large-scale auxiliary infor-
mation is important to the PD research community to adapt or calibrate
the DN model to their own case-speciﬁc simulations in the future.
Furthermore, it is necessary to qualitatively test the accuracy of a do-
paminergic neuronal metabolic model, reﬁne the reconstruction and
corresponding constraint-based computational model, by comparing
the pathways predicted to be active in the model with pathways
established experimentally and in the literature. Many of the relevant
in silico tests can be performed using existing software.
4.3. Determination of the relative importance of variousmetabolic pathways
to neurodegeneration in PD
The degeneration of a single DN in PDmay be the result of perturba-
tions to energy metabolism. All else being equal, this could either be a
decrease in the capacity to produce energy or an increase in demand
for energy. Therefore, PD could either result from impaired function of
metabolic reactions that generate energy or decreased energy efﬁciency
in non-metabolic processes consuming energy, e.g., protein degrada-
tion. The molecular causes and metabolic pathways can be identiﬁed
by understanding the relationship betweenmetabolic reactions already
hypothesised to be important in the pathogenesis of PD, e.g., mitochon-
drial oxidative phosphorylation,with other reactions included in the re-
construction. This can be done by calculating how a change in the rate of
a given reaction would inﬂuence the rate of energy supply toward elec-
trophysiological activity. This may uncover cascading effects of redox
perturbation and over-expression of inﬂammation-associated enzymes
such as cyclooxygenase-2 (COX-2).5 http://www.brain-map.org.Themetabolic mechanisms involved in neurophysiological activities
of DN can be identiﬁed by a number of methods based on sensitivity
analysis [46]. These methods can be implemented to analyse the
trade-off between different metabolic functions of the DN and identify
the maximum reaction rates of the phenotypical behaviours allowed
by physical constraints such as mass balance, with respect to perturba-
tion in the rates of each metabolic reaction.
Speciﬁcally, robustness analysis, as exempliﬁed by previous studies
[47,48], can be performed to test howDNmetabolism adjusts its energy
regeneration mechanisms to meet the known high demand for energy
consumption in a DN [49], while maintaining a steady state. The net-
work robustness is related to the topology of the metabolic model and
can be described by the functional and dynamic changes that result
from perturbations. Robustness analysis can give an insight into the re-
lationship between available energy sources and enzyme ﬂuxes at an
objective-oriented metabolic state.
The steady states can be further constrained by metabolic uptake
rates and the net direction of each metabolic reaction. Further thermo-
dynamic constraints can be added such that steady states are also
thermodynamically feasible. Energy balance analysis [50-52], a comple-
mentary method to FBA, can constrain the solution space and improve
the accuracy of the FBA theoretical prediction by taking into account
thermodynamic principles. However, it is noteworthy that energy
balance analysis can only be conducted on small or medium-sized net-
works and requires the biochemical thermodynamic parameters of all
reactions. Out of this set of steady states, strictly convex optimisation
algorithms [53] can be used to predict a unique steady state reaction
rate for each metabolic reaction, where it is possible to set multiple
weighted optimisation objectives [54], based on known metabolic de-
mands, e.g., energy demand for electrophysiological activity.
There is no human biomass equation available in the literature and a
neuron does not proliferate like a cancer cell or a microorganism. The
objective of the neural cell is thought to achieve different metabolic
functions, such as secretion of a range of metabolites into surrounding
environments. Different objectives have been used in studies applying
constraint-based modelling to calculate an optimal ﬂux distribution.
These objectives includemaximisation of ﬂuxes through apoptosis, pro-
tein degradation, ATP, O2, α-synuclein and tyrosine production path-
ways [27], maximisation of the sum of the ﬂuxes through glutamate/
glutamine/GABA cycles [26], and maximisation of the energy metabo-
lism to increase dopamine release required for neuronal signalling [55].
In contrast to single-objective based studies, it is preferable to em-
ploy Pareto optimality analysis [56] to reveal the competitive and syner-
gic effects among these metabolic functions. This method allows the
evaluation of the impact of any enhanced metabolic activities on the
cellular metabolism. Optimisation of a number of competing objectives
is a well-studied problem and gives rise to the concept of a Pareto front
[56], which is a range of solutions that interpolate between a number
of extremes. At each extreme, one objective is optimised on its own;
in between, the objectives are combined in varying proportions. The
490 L. Mao et al. / Computational and Structural Biotechnology Journal 13 (2015) 484–491objective equation can be formulated as described in previous studies
[33,47,48]. Brieﬂy, a multi-objective equation comprises: 1) one objec-
tive that represents the maintenance energy cost and 2) other objec-
tives that reﬂect different metabolic functions of the neuron. Use of
a multi-objective with adjustable relative contributions is a standard
computational device and was also evaluated for metabolic modelling
[57]. Practical calculations involve maximising a weighted combination
of objective ﬂuxes for a series of ﬁxed λ values — the weighting factor
for the importance of the objective. As commonly found, equally spaced
λ values do not yield equally spaced points on the Pareto front. Suitable
values can therefore be determined by construction of an equispaced
Pareto front using a sequence of optimisation problems as exempliﬁed
in a previous study [56]. In the present context, λ = 0 represents
the metabolic state where ﬂux through the associated objective is not
encouraged by the optimisation, while λ= 1 is the other (in practice
non-viable) extreme where all metabolic resources are devoted to
achieving the objective. Equal weighting may not necessarily represent
actual physiological priorities, but it is appropriate to evaluate how the
objectives mutually inﬂuence each other. In this sense, the value of λ
can also be interpreted as a measure of the degree of perturbation
caused by different objectives — metabolic functions of the DNs.
Then, a fractional beneﬁt analysis, as described previously [47,48],
can be conducted to quantify additional beneﬁt of the trade-off to me-
tabolism between the multiple objectives — how each of the multiple
objective terms contributes (positively or negatively) to the overall ben-
eﬁt. It can also be used to quantify the competitive or synergic effect be-
tween different objectives, for example, ATP and dopamine production.
Furthermore, a number of PD-associated genes have already been
reported, such as those encoding α-synuclein, parkin, PINK1, DJ-1,
LRRK2, and ATP13A [58]. Using the available biochemical knowledge,
it is therefore possible to perform sensitivity analysis for speciﬁc reac-
tions in the metabolic reconstruction to unravel relationships between
the expression of genes encoding these reactions, which are functional-
ly related to the PD-associated genes, and the normal metabolic func-
tions under the pathogenesis of PD diseases.
5. Summary and outlook
PD has a multi-factorial aetiology, involving interaction between
multiple perturbed biochemical reactions. The latest human generic
metabolic reconstruction [21] can be combined with existing and
newly generated high-throughput experimental data to develop a com-
prehensive reconstruction of the dopaminergic neuronal metabolism.
Development of a constraint-based computational model, derived
from the aforementioned reconstruction, is envisaged to predict the
set of metabolic pathways critical for maintenance of normal dopami-
nergic neuronal metabolic function and predict the combination of ge-
netic perturbations that confer selective vulnerability to degeneration
of DNs.
There is a shortage of research activities in the DN reconstruction
and modelling effort. The reconstruction requires not only the manual
reconstruction from the classical neurobiochemical literature, but also
a parallel and complementary effort to apply and adapt existing tools
for automated reconstruction ofmetabolic networks in order to acceler-
ate the comprehensiveness of the existing DN reconstruction and
modelling effort. This permits the incorporation of high-throughput
experimental data, which can be used as an independent means to
establish the activity of individual reactions within DN susceptible to
degeneration in PD. Once the parallel manual and automated recon-
struction effort has resulted in an integrated computational model, it
is possible to combine biochemistry and computational modelling
to determine the relative importance of various factors implicated in
neurodegeneration in PD.
There are several potential challenges in theDN reconstruction. First,
the pipeline methods for network reconstruction are well described by
previous studies [19] but many of these methods were developed formicrobial metabolism reconstruction. It is thus necessary to identify
the difference between microbial and neuronal reconstructions, and to
develop a new computational framework based on existing published
methods, which could involve some unforeseen problems pertaining
to the metabolic difference between DNs and other cell types. Second,
one necessary step during metabolic reconstruction is establishing a
good representation of cellular objectives of the DN for FBA modelling.
This could involve many iterations of in silico testing and veriﬁcation,
as well as comparison with literature and experimental data. In addi-
tion, the quality of the objective function could be undermined by the
experimental error and small sample size of measured data. Third, the
metabolic reconstruction relying on multiple biological databases and
different sources of experimental data may involve inconsistencies or
errors (such as inmetabolite naming),which could require extensive ef-
forts to reconcile and develop methods to standardise the generalised
databases for the DN reconstruction. Therefore, to ensure the integrity
and quality of the reconstruction of DN metabolism, it demands the
combined efforts among computational biologists and biochemists.
A range of age-related processes (e.g., insulin resistance, diabetes
and obesity) might be linked to the pathophysiological mechanisms of
PD, via natural and chronic alterations in whole-body metabolism
[59]. Incorporation of age-related alterations into the computational
model may help elucidate the interplay between age- and PD-related
processes. To unravel the complex relationships between neurodegen-
eration and peripheral alterations in PD, it may also be worthwhile to
develop interaction models based on metabolic reconstructions of DN
and other cells in non-dopaminergic associated areas. These models
may be used to study the interaction between dopamine pathways
in neurons and inﬂammatory and cell death pathways in various types
of glial cells [60] in order to provide a more complete picture of the
aetiology and pathogenesis of PD.
It may be worth noting that the prevalence of PD is 1.5–2 times
higher in men than women [61-64]. Therefore, a future direction for
constraint-based modelling of DNs in PD is to develop gender-speciﬁc
metabolic models to identify underlying mechanisms linking to the
differences between the two sexes. These metabolic models can be re-
constructed based on the omics data from literature mining for sex dif-
ferences in metabolism [65-67] and gene expression proﬁling of male
and female human induced pluripotent stem cells (iPSCs) [44,68], and
has potential to facilitate the design of gender-related therapies for PD
patients.
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